mirtazapine sold brand name remeron amongst others atypical tetracyclic antidepressant used primarily treat effects may take four weeks also manifest early one two often used cases depression complicated anxiety effectiveness mirtazapine comparable commonly prescribed taken common side effects include sleepiness dizziness increased appetite weight serious side effects may include mania low white blood cell count increased suicide among withdrawal symptoms may occur recommended together monoamine oxidase although evidence supporting danger combination unclear use pregnancy works clear may involve blocking certain adrenergic serotonin chemically tetracyclic closely related mianserin also strong antihistaminergic mirtazapine came medical use united states patent expired generic versions commonly prescribed medication united states million mirtazapine approved united states food drug administration treatment major depressive disorder mirtazapine primarily used major depressive disorder mood onset action appears faster selective serotonin reuptake inhibitors similar tricyclic national institute health care excellence recommended generic selective serotonin reuptake inhibitors first line choices equally effective antidepressants favourable respect mirtazapine found difference mirtazapine antidepressants efficacy measure although terms achieving remission mirtazapine appears statistical though clinical advantage addition mirtazapine statistical advantage selective serotonin reuptake inhibitors terms reducing symptoms depression difference clinically significant however strong evidence patients taking mirtazapine less likely leave treatment early side effects although case patients reporting side effects leaving treatment early cochrane review compared mirtazapine antidepressants found appears faster onset people works measured two weeks efficacy antidepressants six weeks review focused antidepressants sleep found many people sleep disorders caused depression mirtazapine reduces time takes fall asleep increases quality sleep people disturb sleep especially higher doses causing restless leg syndrome people rare cases causes rem sleep behavior seemingly paradoxical curve mirtazapine respect somnolence owed exceptionally high affinity drug histamine receptors exhibiting near exclusive occupation receptors doses mg however higher doses inverse agonism constitutive activation receptors begins offset activity receptors leading decreased somnolence even subjective sensation activation treated analysis antidepressants found fairly similar found tentative evidence mirtazapine effective group middle one week usage mirtazapine found earlier onset action compared selective serotonin reuptake also evidence supporting use treating following conditions sometimes prescribed offlabel cochrane review found compared antidepressants likely cause weight gain sleepiness less likely cause tremor tricyclic antidepressants less likely cause nausea sexual dysfunction selective serotonin reuptake common incidence adverse effects include constipation dry mouth sleepiness increased appetite weight gain increase common incidence adverse effects include weakness confusion dizziness fasciculations muscle twitches peripheral edema swelling usually lower limbs negative lab results like elevated transaminases elevated serum triglycerides elevated total mirtazapine considered risk many side effects often associated antidepressants like selective serotonin reuptake inhibitors may actually improve certain ones taken conjunction adverse effects include decreased appetite weight loss insomnia nausea vomiting diarrhea urinary retention increased body temperature excessive sweating pupil dilation sexual general antidepressants especially selective serotonin reuptake inhibitors paradoxically exacerbate peoples depression anxiety cause suicidal despite sedating action mirtazapine also believed capable united states certain countries carries black box label warning potential effects especially people age mirtazapine may induce arthralgia noninflammatory joint case report published noted instance mirtazapine counteracted action clonidine causing dangerous rise blood study comparing antidepressants pharmacological classes mirtazapine one antidepressants likely cause nightmare disorder sleepwalking restless legs syndrome night terrors sleep mirtazapine associated increased risk death compared antidepressants several studies however likely residual differences people prescribed mirtazapine rather selective serotonin reuptake inhibitor account difference risk systematic review literature movement disorders secondary mirtazapine fiftytwo reports containing cases assessed abnormal movements encountered restless legs syndrome tremors akathisia periodic limb movement disorder dystonia rapid eye movement sleep behavior disorder dyskinesia parkinsonism mirtazapine antidepressants may cause withdrawal symptoms upon gradual slow reduction dose recommended minimize withdrawal effects sudden cessation treatment mirtazapine may include depression anxiety tinnitus panic attacks vertigo restlessness irritability decreased appetite insomnia diarrhea nausea vomiting flulike symptoms allergylike symptoms pruritus headaches sometimes mania mirtazapine considered relatively safe event although considered slightly toxic overdose selective serotonin reuptake inhibitors except unlike tricyclic antidepressants mirtazapine showed significant cardiovascular adverse effects times maximum recommended twelve reported fatalities attributed mirtazapine fatal toxicity index deaths per million prescriptions mirtazapine ci similar observed selective serotonin reuptake medical source concurrent use inhibitors inducers cytochrome isoenzymes andor result altered concentrations mirtazapine main enzymes responsible examples fluoxetine paroxetine inhibitors enzymes known modestly increase mirtazapine levels carbamazepine inducer considerably decreases liver impairment moderate chronic kidney disease reported decrease oral clearance mirtazapine severe kidney disease decreases mirtazapine combination selective serotonin reuptake inhibitor reuptake inhibitor tricyclic antidepressant augmentation strategy considered relatively safe often employed therapeutically caution given combined fluvoxamine combination venlafaxine mirtazapine sometimes referred california rocket several case reports document serotonin syndrome induced combination mirtazapine agents tramadol adding fluvoxamine treatment mirtazapine may cause significant increase mirtazapine concentration interaction may necessitate adjustment mirtazapine according information manufacturers mirtazapine started within two weeks monoamine oxidase inhibitor usage likewise monoamine oxidase inhibitors administered within two weeks discontinuing addition mirtazapine monoamine oxidase inhibitor potentially typical idiosyncratic unique individual reactions herein described appear cause serotonin accordance fact receptor predominant serotonin receptor thought involved pathophysiology serotonin syndrome receptor seeming mirtazapine potent receptor antagonist cyproheptadine medication shares property mediates recovery serotonin syndrome antidote possible interaction results hypertensive crisis mirtazapine given patient already steady doses clonidine involves subtle consideration patients chronic therapy clonidine suddenly stop dosing rapid hypertensive rebound sometimes occurs increased sympathetic outflow clonidines blood pressure lowering effects due stimulation presynaptic autoreceptors cns suppress sympathetic outflow mirtazapine blocks autoreceptors effect adding mirtazapine patient stabilized clonidine may precipitate withdrawal mirtazapine sometimes described noradrenergic specific serotonergic antidepressant although actual evidence support label regarded tetracyclic mirtazapine potent antagonist receptors mirtazapine significant affinity receptors mirtazapine potent antagonist histamine receptors property may explain prominent sedative mirtazapine antihistamine antiserotonergic specifically potent antagonist inverse agonist receptors serotonin histamine unlike many antidepressants inhibit reuptake serotonin norepinephrine inhibit monoamine similarly mirtazapine weak activity anticholinergic blocker sodium calcium channels contrast tricyclic accordance better tolerability low toxicity receptor antagonist mirtazapine extremely potent fact potent tricyclic tetracyclic antagonism receptor far strongest activity mirtazapine drug acting selective receptor antagonist low enantiomer mirtazapine responsible antagonism serotonin enantiomer responsible antagonism enantiomers involved antagonism although enantiomer stronger although clinically relevant mirtazapine found act partial agonist κopioid receptor high concentrations antagonism receptors function largely inhibitory autoreceptors heteroreceptors enhances adrenergic serotonergic neurotransmission notably central receptor mediated transmission dorsal raphe nucleus hippocampus hence mirtazapines classification nassa indirect adrenoceptormediated enhancement serotonin cell firing direct blockade inhibitory heteroreceptors located serotonin terminals held responsible increase extracellular medical medical source mirtazapine said functional indirect agonist increased activation central receptor thought major mediator efficacy antidepressant antagonism subfamily receptors inverse agonism receptor appears part responsible mirtazapines efficacy treatment depressive mirtazapine increases dopamine release prefrontal accordingly shown blocking receptors receptors mirtazapine disinhibited dopamine norepinephrine activity areas addition mirtazapines antagonism receptors beneficial effects anxiety sleep appetite well sexual function regarding latter mirtazapine shown lower drug seeking behaviour specifically methamphetamine various human animal also investigated substance abuse disorders reduce withdrawal effects improve remission mirtazapine significantly improves preexisting symptoms nausea vomiting diarrhea irritable bowel syndrome affected mirtazapine may used inexpensive antiemetic alternative conjunction substance abuse counseling mirtazapine investigated purpose reducing methamphetamine use dependent individuals contrast mirtazapine selective serotonin reuptake inhibitors reuptake inhibitors monoamine oxidase inhibitors tricyclic antidepressants increase general activity receptors leading host negative changes side effects prominent including anorexia insomnia nausea diarrhea among others reduced incidence sexual dysfunction loss libido anorgasmia could product negligible binding serotonin transporter generally cause sexual dysfunction selective serotonin reuptake inhibitors antagonism receptors however mirtazapines high affinity towards inverse agonism receptors may greatly attenuate prosexual factors evidenced prosexual effects drugs like mcpp lorcaserin agonize receptors reasonably selective manner result often combined drugs reduce sideeffect profile produce stronger antidepressant mirtazapine proserotonergic activity thus cause serotonin accordance fact serotonin reuptake inhibitor monoamine oxidase inhibitor serotonin receptor reports serotonin syndrome association mirtazapine alone mirtazapine found cause serotonin syndrome however handful case reports serotonin syndrome occurring mirtazapine combination serotonergic drugs like selective serotonin reuptake inhibitors although reports rare necessarily implicate mirtazapine potent blocker may relieve chemotherapyrelated advanced cancerrelated mirtazapine strong receptor antagonist result cause powerful sedative hypnotic single mg dose mirtazapine healthy volunteers found result occupancy receptor induce intense short period chronic treatment however receptor tends desensitize antihistamine effects become tolerable many patients may also dose night avoid effects appears effective strategy combating blockade receptor may improve preexisting allergies pruritus nausea insomnia affected individuals may also contribute weight gain however contrast receptor mirtazapine low affinity muscarinic acetylcholine receptors although anticholinergic side effects like dry mouth constipation mydriasis still sometimes seen clinical oral bioavailability mirtazapine found mostly bound plasma proteins metabolized primarily liver ndemethylation hydroxylation via cytochrome enzymes overall elimination halflife hours independent conjugated kidney excretion urine drug eliminated desmethylmirtazapine active metabolite mirtazapine believed contribute drugs overall effects halflife mirtazapine tetracyclic piperazinoazepine mianserin developed team organic chemists mirtazapine differs via addition nitrogen atom one racemic mixture enantiomers senantiomer known esmirtazapine analogues mirtazapine include mianserin setiptiline aptazapine chemical synthesis mirtazapine published first step synthesis condensation reaction molecule molecule mirtazapine first synthesized organon published first approved use major depressive disorder netherlands introduced united states brand name therapeutic levels mirtazapine found blood film director tony scott autopsy suicide mirtazapine english french generic name drug inntooltip international nonproprietary name usantooltip united states adopted name usptooltip united states pharmacopeia bantooltip british approved name dcftooltip dénomination commune française jantooltip japanese accepted generic name spanish italian portuguese mirtazapina german swedish mirtazapine marketed many brand names worldwide including adcomirteron afloyan amirel arintapin smelt avanza axit azapin beron bilanz blumirtax calixta ciblex combar comenter depreram divaril esprital maz menelat mepirzapine merdaten meronin mi er ning milivin minelza minivane mirastad mirazep miro miron mirrador mirt mirta mirtabene mirtadepi mirtagamma mirtagen mirtalan mirtamor mirtamylan mirtan mirtaneo mirtapax mirtapil mirtapine mirtaron mirtastad mirtax mirtaz mirtazap mirtazapin mirtazapina mirtazapine mirtazapinum mirtazelon mirtazon mirtazonal mirtel mirtimash mirtin mirtine mirtor mirzapine mirzaten mirzest mitaprex mitaxind mitocent mitrazin mizapin motofen mytra norset noxibel pharmataz promyrtil rapizapine ramure razapina redepra reflex remergil remergon remeron remirta rexer saxib sinmaron smilon tazepin tazimed tetrazic tifona umirtaron uzepine valdren vastat velorin yarocen zania zapex zestat zismirt zispin zuleptan use mirtazapine explored several additional conditions mirtazapine also veterinary use cats dogs mirtazapine sometimes prescribed appetite stimulant cats dogs experiencing loss appetite due medical conditions chronic kidney disease especially useful treating combined poor appetite nausea cats mirtazapine indicated bodyweight gain cats experiencing poor appetite weight loss resulting chronic medical two options administration tablets given orally ointment applied topically inner surface common side effects include signs local irritation inflammation site ointment applied behavioural changes increased meowing hyperactivity disoriented state inability coordinate muscle movements lack energyweakness attentionseeking httpsenwikipediaorgwikimirtazapine